Premium
Investigation of papulopustular eruptions caused by cetuximab treatment shows altered differentiation markers and increases in inflammatory cytokines
Author(s) -
Han S.S.,
Lee M.,
Park G.H.,
Bang S.H.,
Kang Y.K.,
Kim T.W.,
Lee J.L.,
Chang H.M.,
Ryu M.H.
Publication year - 2010
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2009.09536.x
Subject(s) - filaggrin , medicine , papulopustular , involucrin , cetuximab , tumor necrosis factor alpha , pathology , cancer research , proinflammatory cytokine , immunology , inflammation , biology , dermatology , keratinocyte , monoclonal antibody , antibody , atopic dermatitis , biochemistry , rosacea , in vitro , acne
Summary Background Epidermal growth factor receptor (EGFR) critically regulates tumour cell division, survival and metastasis. Agents that inhibit EGFR have been used in the treatment of advanced‐stage malignancies, but cause variable cutaneous side‐effects, most often papulopustular eruptions and xerosis. Objectives We assayed expression of inflammatory cytokines [interleukin (IL)‐1α, tumour necrosis factor (TNF)‐α, interferon (IFN)‐γ, human leucocyte antigen (HLA)‐DR and intercellular adhesion molecule (ICAM)‐1], differentiation markers (filaggrin, involucrin and loricrin) and phosphorylated EGFRs (pEGFRs) in papulopustular eruptions to determine the association between these markers and the eruptions caused by cetuximab. Patients/methods Twelve papulopustular lesion biopsies were selected from patients with colon cancer who had received cetuximab treatment. Immunohistochemistry and immunofluorescence with a confocal laser scanning microscopy were performed. Results Filaggrin expression decreased and expression of involucrin, various inflammatory markers (IL‐1α, TNF‐α, ICAM‐1 and HLA‐DR) increased and the expression of pEGFR was markedly downregulated in papulopustular eruptions. In perilesions, decreased pEGFR expression was noted in hair follicles compared with interfollicular epidermis. The increase of IL‐1α and TNF‐α was observed in perilesions as in the lesions. Conclusions The early inflammatory events (IL‐1α and TNF‐α expression) seen, and the lack of pEGFR in perilesional follicles, indicate that inflammatory events induced by EGFR inhibition may initiate papulopustular eruptions along with the altered differentiations. The decrease of filaggrin may contribute to the pathogenesis of the xerosis caused by cetuximab.